A New Patent Could Be The Golden Ticket For This Biotech Stock
Avinger, Inc. (NASDAQ: AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD), announced the issuance of a new U.S. patent related to the Company's proprietary optical coherence tomography (OCT) intravascular imaging system. The Company also announced the...